Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports
作者： Grace C Lee , David S Burgess
关键词:
摘要: … Although polymyxins were the most commonly used antimicrobial against KPC infections in this review, the effectiveness of polymyxins for the treatment of KPC infections is not well …
biomedcentral.com
springer.com
core.ac.uk
doaj.org参考文章(72)
Elisa Maria Beirão, Juvencio Jose Duailibe Furtado, Raquel Girardello, Heli Ferreira Filho, Ana Cristina Gales, Clinical and microbiological characterization of KPCproducing Klebsiella pneumoniae infections in Brazil Brazilian Journal of Infectious Diseases. ,vol. 15, pp. 69- 73 ,(2011) , 10.1016/S1413-8670(11)70143-X
Jennifer Le, Barbara McKee, Warunee Srisupha-Olarn, David S Burgess, In Vitro Activity of Carbapenems Alone and in Combination With Amikacin Against KPC-Producing Klebsiella Pneumoniae Journal of Clinical Medicine Research. ,vol. 3, pp. 106- 110 ,(2011) , 10.4021/JOCMR551W
A. Tsakris, K. Themeli-Digalaki, A. Poulou, G. Vrioni, E. Voulgari, V. Koumaki, A. Agodi, S. Pournaras, D. Sofianou, Comparative Evaluation of Combined-Disk Tests Using Different Boronic Acid Compounds for Detection of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Clinical Isolates Journal of Clinical Microbiology. ,vol. 49, pp. 2804- 2809 ,(2011) , 10.1128/JCM.00666-11
R.S. Leão, A. P. D' A. Carvalho-Assef, J.C.D. Correal, R.V. Silva, D.C. Goldemberg, M.D. Asensi, E.A. Marques, KPC-2 producing Klebsiella pneumoniae and Escherichia coli co-infection in a catheter-related infection Clinical Microbiology and Infection. ,vol. 17, pp. 380- 382 ,(2011) , 10.1111/J.1469-0691.2010.03268.X
Hanna E. Sidjabat, Fernanda P. Silveira, Brian A. Potoski, Kareem M. Abu‐Elmagd, Jennifer M. Adams‐Haduch, David L. Paterson, Yohei Doi, Interspecies Spread of Klebsiella pneumoniae Carbapenemase Gene in a Single Patient Clinical Infectious Diseases. ,vol. 49, pp. 1736- 1738 ,(2009) , 10.1086/648077
H.C. Maltezou, P. Giakkoupi, A. Maragos, M. Bolikas, V. Raftopoulos, H. Papahatzaki, G. Vrouhos, V. Liakou, A.C. Vatopoulos, Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). Journal of Infection. ,vol. 58, pp. 213- 219 ,(2009) , 10.1016/J.JINF.2009.01.010
Alison K. Meagher, Paul G. Ambrose, Thaddeus H. Grasela, Evelyn J. Ellis‐Grosse, The Pharmacokinetic and Pharmacodynamic Profile of Tigecycline Clinical Infectious Diseases. ,vol. 41, ,(2005) , 10.1086/431674
P. E. Akpaka, W. H. Swanston, H. N. Ihemere, A. Correa, J. A. Torres, J. D. Tafur, M. C. Montealegre, J. P. Quinn, M. V. Villegas, Emergence of KPC-Producing Pseudomonas aeruginosa in Trinidad and Tobago Journal of Clinical Microbiology. ,vol. 47, pp. 2670- 2671 ,(2009) , 10.1128/JCM.00362-09
A. Endimiani, J. M. DePasquale, S. Forero, F. Perez, A. M. Hujer, D. Roberts-Pollack, P. D. Fiorella, N. Pickens, B. Kitchel, A. E. Casiano-Colon, F. C. Tenover, R. A. Bonomo, Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. Journal of Antimicrobial Chemotherapy. ,vol. 64, pp. 1102- 1110 ,(2009) , 10.1093/JAC/DKP327
Catharine C. Bulik, Henry Christensen, Peng Li, Christina A. Sutherland, David P. Nicolau, Joseph L. Kuti, Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against Klebsiella pneumoniae Producing the KPC Carbapenemase versus That against Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model Antimicrobial Agents and Chemotherapy. ,vol. 54, pp. 804- 810 ,(2010) , 10.1128/AAC.01190-09